Reading this clinical breakthrough? See how real patients are applying these numbers in real life. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Official NIH NLM MEDLINE / PubMed Citation • PMID: 42975717

Oncologic efficacy and safety of stereotactic body radiotherapy for oligometastatic non-small cell lung cancer: a systemic meta-analysis

Clinical & experimental metastasis

Verbatim Formal Study Abstract

This meta-analysis indicates that SBRT yields favorable treatment outcomes for patients with oligometastatic NSCLC with manageable toxicities. When anatomically feasible, delivering an ablative dose-100 Gy 10 in biologically effective dose-is recommended.